Search

Author/Creator Konopleva, M.

1. 89 A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML). Issue 1 (April 2015)

Authors:
Navada, S.C.; Garcia-Manero, G.; Hearn, K.; Odchimar-Reissig, R.; Demakos, E.; Alvarado, Y.; Daver, N.; DiNardo, C.; Konopleva, M.; Borthakur, G.; Azarnia, N.; Silverman, L.R.
Journal:
Leukemia research
Issue:
Volume 39:Issue 1(2015:Jan.)
Page Start:
S45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of the Type of First-Cancer Therapy in Therapy-Related Myelodysplastic Syndromes Outcomes. (April 2017)

Authors:
Pierola, A. Alfonso; Guillermo, M.B.; Takahashi, K.; Jabbour, E.J.; Jadua, T.; Ravandi, F.; Cortes, J.; DiNardo, C.; Daver, N.; Borhtakur, G.; Pemmaraju, N.; Konopleva, M.; Bueso-Ramos, C.; Pierce, S.; Kantarjian, H.; Garcia-Manero, G.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL. (23rd June 2022)

Authors:
Jain, N.; Roboz, G.; Konopleva, M.; Liu, H.; Schiller, G.; Jabbour, E.; Desai, P.; Whitfield, D.; Haider, A.; Zernovak, O.; Frattini, M.; Brownstein, C.; Larson, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WITHOUT BLINATUMOMAB, IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATES FROM A PHASE II TRIAL. (23rd June 2022)

Authors:
Haddad, F.; Kantarjian, H.; Short, N.; Ravandi, F.; Jain, N.; Macaron, W.; Kadia, T.; Alvarado, Y.; Daver, N.; Borthakur, G.; DiNardo, C.; Konopleva, M.; Wierda, W.; Jacob, J.; Roy, E.; Loiselle, C.; Milton, A.; Rivera, J.; Garris, R.; Jabbour, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL). (23rd June 2022)

Authors:
Ravandi, F.; Jabbour, E.; Jain, N.; Kadia, T.; Gautam, B.; Konopleva, M.; Wierda, W.; Burger, J.; Issa, G.; Maiti, A.; Balkin, H.; Kelly, M.; Garris, R.; Kebriaei, P.; Ferrajoli, A.; Garcia-Manero, G.; Alvarado, Y.; Short, N.; Kantarjian, H.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Jabbour, E. J.; Short, N. J.; Ravandi, F.; Kebriaei, P.; Kadia, T. M.; Borthakur, G.; Pemmaraju, N.; Garris, R. S.; Bansal, D.; Konoplev, S.; Wang, S.; Wang, W.; Tang, G.; Patel, K. P.; Konopleva, M.; Jain, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Kantarjian, H.; Short, N.; Alvarado, Y.; Burger, J.; Jain, N.; Konopleva, M.; Ravandi, F.; DiNardo, C.; Masarova, L.; Sasaki, K.; Thompson, P. A.; Ferrajoli, A.; Jacob, J. O.; Mayor, E. D.; Milton, A. M.; Loiselle, C.; Garris, R. S.; Jabbour, E. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Kantarjian, H.; Short, N.; Konopleva, M.; Ravandi, F.; Jain, N.; Thompson, P. A.; Pemmaraju, N.; Wierda, W. G.; Borthakur, G.; Kadia, T. M.; Garcia-Manero, G.; Yilmaz, M.; Thankachan, J.; Zhao, M.; Loiselle, C.; Talley, M. T.; Kwari, M. I.; Garris, R. S.; Jabbour, E. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Short, N.; Kantarjian, H.; Ravandi, F.; Yilmaz, M.; Kadia, T.; Thompson, P.; Huang, X.; Konopleva, M.; Ferrajoli, A.; Jain, N.; Sasaki, K.; Alvarado, Y.; Borthakur, G.; Dinardo, C.; Ohanian, M.; Macaron, W.; Kornblau, S.; Zhao, M.; Kwari, M.; Loiselle, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search